Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myocardial infarction after taking zolmitriptan.

Roberto Pacheco-Coronado1, Paul W McMullan, Brian H Galbut

  • 1Rush University Medical Center, Chicago, Illinois, USA.

The Yale Journal of Biology and Medicine
|February 9, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic Spontaneous Coronary Artery Dissection in a Young Woman Managed With Coronary Artery Bypass Grafting: A Case Report With Literature Review.

Clinical case reports·2026
Same author

Lessons of Macrophage-Associated Heart Regeneration in Fish, Amphibians, and Neonatal Mice, Applied to Adult Mice: A Perspective on α-Gal Nanoparticles.

International journal of molecular sciences·2026
Same author

Corrigendum to '2025 SCAI/HRS Clinical Practice Guidelines on Transcatheter Left Atrial Appendage Occlusion': [Journal of the Society for Cardiovascular Angiography & Interventions. Volume 4, Issue 9 (2025) 103783].

Journal of the Society for Cardiovascular Angiography & Interventions·2026
Same author

Left Ventricular Health and TAVR Timing in Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial.

Journal of the American College of Cardiology·2025
Same author

2025 SCAI/HRS Clinical Practice Guidelines on Transcatheter Left Atrial Appendage Occlusion.

Journal of the Society for Cardiovascular Angiography & Interventions·2025
Same author

Syphilitic Mitral Valve Endocarditis: Diagnostic Challenges and Clinical Management.

JACC. Case reports·2025

Zolmitriptan, a migraine treatment, may cause heart attacks (myocardial infarction) even in patients without significant coronary artery disease. This risk highlights the importance of careful patient selection for migraine pharmacotherapy.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Migraine headaches are a common neurological disorder.
  • Triptans, such as zolmitriptan, are frequently used for acute migraine treatment.
  • Coronary artery disease (CAD) is a known risk factor for myocardial infarction (MI).

Observation:

  • A patient with mild, non-obstructive CAD experienced an inferior wall MI after taking zolmitriptan.
  • A literature review identified other cases of MI associated with zolmitriptan and similar migraine medications.

Findings:

  • Zolmitriptan use is potentially linked to myocardial infarction.
  • This association may occur even in individuals with minimal or no significant coronary artery disease.

Implications:

Related Experiment Videos

  • Clinicians should consider the potential cardiovascular risks of zolmitriptan, especially in patients with risk factors for CAD.
  • Further research is warranted to elucidate the mechanisms and precise risk stratification for zolmitriptan-induced MI.
  • Alternative migraine therapies may be considered for patients with underlying cardiovascular concerns.